NCT01393990 2020-03-24
A Study of LY2228820 in Participants With Advanced Cancer
Eli Lilly and Company
Phase 1 Completed
Clinical Trials
4 trialsNCT02364206 2019-08-14
GLYRad
Centre Jean Perrin
Phase 1/2 Completed
NCT02860780 2018-12-14
A Study of Prexasertib (LY2606368) in Combination With Ralimetinib in Participants With Advanced or Metastatic Cancer
Eli Lilly and Company
Phase 1 Completed
NCT02322853 2017-05-24
OLYMPE
Centre Francois Baclesse
Phase 2 Terminated